Eloxx Pharmaceuticals, Inc.

Biopharmaceutical company $ELOX is down over 50% on the day as of now and the biggest loser on the Prism MarketView Pharmaceuticals index. The reason for the drop is that it was revealed Friday, that it is being delisted from NASDAQ

Share This Article

 

About the Author

Eloxx Pharmaceuticals, Inc.

Joey Ramson